Which of the following findings support the diagnosis of primary biliary cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Findings Supporting Primary Biliary Cholangitis

The correct answers are b (AMA positive) and c (elevated alkaline phosphatase), as these are the two hallmark diagnostic criteria for PBC according to current guidelines.

Core Diagnostic Criteria for PBC

The diagnosis of PBC requires two key findings 1:

  • Positive antimitochondrial antibodies (AMA) at a titer ≥1:40 by immunofluorescence, which are detected in more than 90% of PBC patients with specificity greater than 95% 1
  • Elevated alkaline phosphatase (ALP) of hepatobiliary origin for at least 6 months, representing the cholestatic pattern characteristic of PBC 1

The combination of abnormal serum ALP and presence of AMA (≥1:40) allows confident diagnosis of PBC 1

Analysis of Each Answer Choice

Option A: AST, ALT elevated >5x ULN - INCORRECT

  • Aminotransferases in PBC are typically normal or only mildly elevated, not markedly elevated 2
  • In early-stage PBC, 50% have normal ALT and 37.5% have normal AST 2
  • When elevated, ALT and AST levels are usually <3 times the upper limit of normal 2
  • Marked transaminase elevation (>5x ULN) suggests autoimmune hepatitis or other hepatocellular injury, not PBC 3

Option B: AMA positive - CORRECT

  • AMA is the diagnostic hallmark and mandatory test for all adults with chronic intrahepatic cholestasis 1
  • Positive at titer ≥1:40, with specificity >95% for PBC 1
  • Anti-AMA-M2 (anti-PDC-E2) can be used as alternative with even higher sensitivity and specificity 1

Option C: Elevated alkaline phosphatase - CORRECT

  • ALP elevation is a sensitive marker for PBC diagnosis, though not specific 4
  • Represents the cholestatic biochemical pattern essential for diagnosis 1
  • Must confirm hepatobiliary origin using GGT or ALP fractionation, as bone-derived ALP can confound interpretation in post-menopausal women 1

Option D: Magnetic cholangiography showing strictures & dilations - INCORRECT

  • This describes primary sclerosing cholangitis (PSC), not PBC 4
  • PSC shows multifocal strictures and beading on MRCP/ERCP 4
  • PBC does not have characteristic cholangiographic abnormalities 1
  • The guidelines explicitly state that AMA positivity should raise suspicion of alternative diagnoses when typical cholangiographic features are present 4

Option E: ANA positive, SMA positive - INCORRECT for PBC alone

  • These antibodies suggest autoimmune hepatitis, not PBC 3
  • ANA is positive in 80% and SMA in 63% of autoimmune hepatitis patients 3
  • When present with PBC features, this suggests PBC-autoimmune hepatitis overlap syndrome, which requires liver biopsy for confirmation 1, 3
  • In AMA-negative patients, specific ANA patterns (anti-Sp100, anti-gp210) can support PBC diagnosis, but general ANA/SMA positivity points toward autoimmune hepatitis 1

Important Clinical Caveats

AMA-positive patients with normal ALP deserve special attention:

  • 80-82% of AMA-positive patients with normal ALP have histological PBC on liver biopsy 5, 6
  • These patients should be monitored with annual biochemical reassessment 1
  • GGT may be more robustly elevated than ALP in early PBC, with 29.2% having normal ALP but significantly elevated GGT 2
  • Current guidelines may not capture the full spectrum of PBC presentation 5

In AMA-negative cases:

  • Specific ANA patterns (anti-Sp100, anti-gp210) have >95% specificity for PBC and can serve as diagnostic markers 1
  • Liver biopsy should be considered in patients with unexplained cholestasis and negative AMA 1, 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.